1Miller G, Pillarisetty VG, Shah AB, et al. Endogenou granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function [ J ]. Immunology, 2002,169 (6) :2875 -2885.
2Santin AD, Bellone S, Palmieri M, et al. Induction of tumor-specific cytotoxicity in tumor infihrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix [ J ]. Gynecol Oncol, 2003,89 (2) :271 - 280.
3Bubenik J. Genetically modified cellular vaccines for therapy of human papi/loma virus type 16 ( HPV 16 ) - associated turnouts [J]. Curr Cancer Drug Targets ,2008, 8(3) :180 - 186.
4Santin AD, Bellone S, Palmieri M, et al. Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or II A cervical cancer patients : a phase I escalating-dose trial [ J ]. Virology, 2008,82 (4) : 1968 - 1979.
5Muderspach L, Wilczynski S, Roman L, et al. A plase I trail of a human papillomavirus (HPV) peptide vaccine for human with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive [J]. Clin Cancer Res,2000,6(9) :3406 -3416.
6Adams M, Navabi H, Jasani B, et al. Dendritic cell ( DC ) based therapy for cervical cancer:use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [ I] :poly[ C(12) U] ( Ampligen R) [ J]. Vaccine,2003, 21(7-8) :787 -790.
8Hung CF, Monie A, Alvarez RD,et al. DNA vaccines for cervical cancer: from bench to bedside [ J ]. Exp Mol Med ,2007,39 (6) :679 - 689.
9Kim D, Hoory T, Wu TC, et al. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cell [J]. Hum Gene Ther,2007,18( 11 ) : 1129 - 1139.
10Kyte JA, Mu L, Aamdal S, et al. Phase I/II trial of meanoma therapy with dendritic cells transfected with autoogous tumor-mRNA [ J]. Cancer Gene Ther,2006, 13(10) :905 -918.
二级参考文献6
1Carole L,An-Lin X,Douglas H,et al.Induction of human tumor-loaded dendritic cells.Int J Cancer,2001,91:438～447.
2Lipscomb MF,Masten BJ.Dendritic cells:Immune regulators in health and disease. Physiol Rev,2002,82:97～130.
3Somersan S,Larsson M,Fonteneau JF,et al.Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol,2001,167(9):4844～4852.
4Singh-Jasuja H,Scherer HU,Hilf N,et al.The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor.Eur J Immunol,2000,30(18):2211～2215.
5Tare K,Klein B.Dendritic cell-based vaccine:a promising approach for cancer immunotherapy.Leukemia,1999,13(5):653～663.
